Navigation Links
Biofrontera in Medical Technology

Ad hoc: Interim report about clinical trial of BF-200 ALA in actinic keratosis

... LEVERKUSEN, Germany, 30 April 2007 - biofrontera AG announced that an interim report regarding the ...zed the clinical results 12 weeks after treatment. biofrontera expects this second report within few weeks. ...plete analysis of the 12-week data. On this basis, biofrontera intends to continue the further development of the...

Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis

... LEVERKUSEN, Germany - biofrontera AG (DSE: B8F) announces today that it has received... superior to the other doses tested. Consequently, biofrontera will conduct additional studies to verify the safe..." commented Prof. Dr. Hermann Lübbert, CEO of biofrontera AG. About...
Biofrontera in Biological Technology

Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT

...ife and mental well-being. Recent Developments biofrontera AG of Germany, listed on Frankfurt Stock Exchange ...erine for the treatment of Eczema and Psoriasis to biofrontera will rapidly develop product extentions and new ch...n upfront fee valued at approxiametely $175,000 in biofrontera shares will augment revenues by a minimum of $240,...
Biofrontera in other areas

Biofrontera | Home

Biofrontera.com ... shows efficacy in severe chronic urticaria. PDF-File. 24 July 2009. Ad-hoc: Biofrontera AG decides to increase its base capital. PDF-File ...

Biofrontera | Ad-hoc: January 14, 2009

Biofrontera.com ... Leverkusen, 14 January 2009 – Biofrontera AG (ISIN: DE 0006046113) has placed a ... Biofrontera AG. Hemmelrather Weg 201, 51377 Leverkusen, ...

Article: Biofrontera Wins Grant - Pharmaceutical Technology Europe

Register today for a free trial, credit card req'd. Find Pharmaceutical Technology Europe articles plus many other academic journal articles, magazine articles & news...

Biofrontera AG - Company Profile - BioCentury

Biofrontera's detailed financials; Comprehensive pipeline breakdown, including ... www.biofrontera.com. Development Status. Phase III (05/13/2009) Archive ...

Biofrontera</b> Strengthens Its Dermatology Drug Pipeline By Acquiring ...

http://www.biofrontera.com/ About InterPharmaLink ... Biofrontera Pharmaceuticals GmbH. • Biotech/Pharma - Mergers and Acquisitions ...

Special versions of DAx

Special versions of DAx Data Analysis software ... with Biofrontera's biochemical engineers and computer programmers. Click here to read what Biofrontera has ...
Other Tags
(Date:8/3/2015)... ... 03, 2015 , ... Novatus, Inc. today launched the largest ... well as announced the date of its next major release. , Version 6.0 ... tasks as well as enhancements to the customer experience. Users now enjoy ...
(Date:8/3/2015)... ... , ... AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative ... Conference on Wednesday, August 12, 2015 at 9:45am (ET) at Le Parker Meridien in ... presentation may be accessed via the investor relations section of the Company’s website. , ...
(Date:8/3/2015)... ... ... The U.S. Food and Drug Administration (FDA) recently approved a new non-invasive ... occurs naturally in the body and helps absorb and breakdown fat cells. Previously, plastic ... These are invasive procedures and very expensive for most people. Now with Kybella, there ...
(Date:8/3/2015)... ... , ... From 2006-2017 the number of dental laboratories in ... compiled for the National Association of Dental Laboratories ( NADL ) by Valmont ... Statistics. As the number of dental laboratories decreases, dentists will have fewer options ...
(Date:8/3/2015)... ... 03, 2015 , ... Hub International Insurance Services ... joined its growing California employee benefits division. Mr. Williams will be responsible ... Mr. Williams will be joining the newly integrated Northern California employee benefits team ...
Breaking Medicine News(10 mins):Health News:Novatus Unveils Milestone Software Release 2Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2
(Date:7/21/2015)... Today, ZTE announced its Android smartphone Axon, featuring FPC,s ... in 2015 that relate to sales of FPC1025 for this smartphone ... MSEK for 2015. Jörgen Lantto, CEO of FPC, comments: ... China and we are proud that ... Axon , its first smartphone ...
(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
Other Contents